Impli

Curated by Signal

Provider of real-time hormone monitoring device for IVF

Overview

Impli offers the first real-time hormone monitoring device for IVF, with the goal of making fertility treatment more accessible, safer, and more successful. They also provide subdermal implants that use NFC technology to communicate with any recent device.

Key facts

Founded: 2019
Headquarters: London, United Kingdom
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Transdermal Diagnostics
Provider of a needle-free continuous glucose monitoring device
Life Sciences TechnologyBath, United Kingdom
Acrobot
Robotic Navigation System for orthopedic surgery
Life Sciences TechnologyLondon, United Kingdom
Living DNA
Online platform offering genetic tests for ancestry analysis
Life Sciences TechnologyFrome, United Kingdom

About Impli

What does Impli do?

Impli offers the first real-time hormone monitoring device for IVF, with the goal of making fertility treatment more accessible, safer, and more successful.

Where is Impli headquartered?

Impli is headquartered in London, United Kingdom.

When was Impli founded?

Impli was founded in 2019.

Which sector is Impli in?

Impli operates in Life Sciences Technology.

Who are Impli's competitors?

Companies similar to Impli include Transdermal Diagnostics, Acrobot, and Living DNA.